Cormorant Private Healthcare Fund V LP — SEC Form 4 filings
SEC reporting owner CIK 1969296. 4 Form 4 filings on record with FilingPulse; latest filed 2026-08-10.
Transaction summary — filings shown
Covers all 4 filings on record, filed 2024-10-01 to 2026-08-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 762,500 shares, $13,100,000 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 1,837,739 shares, $3,411,258 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: purchase of 450,000 shares @ $18.00 ($8,100,000) in BioAge Labs, Inc., filed 2024-10-01.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BioAge Labs, Inc. (BIOA) | — | 1 | 1 leg · 450,000 sh · $8,100,000 | — | 2 |
| BlossomHill Therapeutics, Inc. (BLSM) | 10% owner | 1 | 1 leg · 312,500 sh · $5,000,000 | — | 5 |
| OnKure Therapeutics, Inc. (OKUR) | — | 2 | — | 2 legs · 1,837,739 sh · $3,411,258 | — |
Form 4 filings — Cormorant Private Healthcare Fund V LP
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-10 | 4 | BlossomHill Therapeutics, Inc. (BLSM) jointly with Chen Bihua, Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund III LP, Cormorant Private Healthcare Fund VI, LP | Conversion (C): 1,599,993 · Conversion (C): 1,701,541 · Purchase (P): 312,500 @ $16 · Grant/award (A): 23,904 (derivative) @ $0 · Conversion (C): 1,599,993 (derivative) · Conversion (C): 1,701,541 (derivative) | EDGAR |
| 2025-05-19 | 4 | OnKure Therapeutics, Inc. (OKUR) jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund III LP, Cormorant Private Healthcare Fund IV LP, Chen Bihua | Sale (S): 1,813,439 @ $1.85 | EDGAR |
| 2025-05-14 | 4 | OnKure Therapeutics, Inc. (OKUR) jointly with Cormorant Asset Management, LP, Cormorant Global Healthcare Master Fund, LP, Cormorant Private Healthcare Fund III LP, Cormorant Private Healthcare Fund IV LP, Chen Bihua | Sale (S): 24,300 @ $1.99 | EDGAR |
| 2024-10-01 | 4 | BioAge Labs, Inc. (BIOA) jointly with Cormorant Asset Management, LP, Chen Bihua, Cormorant Private Healthcare Fund IV LP | Conversion (C): 1,179,529 · Purchase (P): 450,000 @ $18 · Conversion (C): 5,263,772 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1969296 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →